Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Providing appropriate genetic information to healthy carriers of hemoglobinopathy can be a welcome and safe initiative: the Latium example.

Amato A, Lerone M, Grisanti P, Gizzi L, Kaufmann JO, Giordano PC.

Genet Test Mol Biomarkers. 2012 Jul;16(7):734-8. doi: 10.1089/gtmb.2011.0290. Epub 2012 Jun 25.

PMID:
22731645
2.

Prevention strategies for severe hemoglobinopathies in endemic and nonendemic immigration countries: the Latium example.

Amato A, Grisanti P, Lerone M, Ponzini D, Di Biagio P, Cappabianca MP, Giordano PC.

Prenat Diagn. 2009 Dec;29(12):1171-4. doi: 10.1002/pd.2382.

PMID:
19816879
3.

After the introduction into the national newborn screening program: who is receiving genetic counseling for hemoglobinopathies in the Netherlands?

Kaufmann JO, Krapels IP, Van Brussel BT, Zekveld-Vroon RC, Oosterwijk JC, van Erp F, van Echtelt J, Zwijnenburg PJ, Petrij F, Bakker E, Giordano PC.

Public Health Genomics. 2014;17(1):16-22. doi: 10.1159/000355223. Epub 2013 Nov 8.

PMID:
24216604
4.

Carrier screening for thalassemia and hemoglobinopathies in Canada.

Langlois S, Ford JC, Chitayat D, D├ęsilets VA, Farrell SA, Geraghty M, Nelson T, Nikkel SM, Shugar A, Skidmore D, Allen VM, Audibert F, Blight C, Gagnon A, Johnson JA, Wilson RD, Wyatt P; CCMG Prenatal Diagnosis Committee.; SOGC Genetic Committee..

J Obstet Gynaecol Can. 2008 Oct;30(10):950-71. Review. English, French.

PMID:
19038079
5.

Three-month follow-up of Western and non-Western participants in a study on preconceptional ancestry-based carrier couple screening for cystic fibrosis and hemoglobinopathies in the Netherlands.

Lakeman P, Plass AM, Henneman L, Bezemer PD, Cornel MC, ten Kate LP.

Genet Med. 2008 Nov;10(11):820-30. doi: 10.1097/GIM.0b013e318188d04c.

PMID:
18941425
6.

Hemoglobinopathy carrier prevalence in the United Arab Emirates: first analysis of the Dubai Health Authority premarital screening program results.

Belhoul KM, Abdulrahman M, Alraei RF.

Hemoglobin. 2013;37(4):359-68. doi: 10.3109/03630269.2013.791627. Epub 2013 May 7.

PMID:
23647352
8.

Prenatal screening for hemoglobinopathies. II. Evaluation of counseling.

Loader S, Sutera CJ, Walden M, Kozyra A, Rowley PT.

Am J Hum Genet. 1991 Mar;48(3):447-51.

9.

Prenatal hemoglobinopathy screening. IV. Follow-up of women at risk for a child with a clinically significant hemoglobinopathy.

Loader S, Sutera CJ, Segelman SG, Kozyra A, Rowley PT.

Am J Hum Genet. 1991 Dec;49(6):1292-9.

10.

Providing genetic risk information to parents of newborns with sickle cell trait: role of the general practitioner in neonatal screening.

Vansenne F, de Borgie CA, Legdeur M, Spauwen MO, Peters M.

Genet Test Mol Biomarkers. 2011 Oct;15(10):671-5. doi: 10.1089/gtmb.2010.0232. Epub 2011 May 16.

PMID:
21574852
11.

Genetic counseling following the detection of hemoglobinopathy trait on the newborn screen is well received, improves knowledge, and relieves anxiety.

Kladny B, Williams A, Gupta A, Gettig EA, Krishnamurti L.

Genet Med. 2011 Jul;13(7):658-61. doi: 10.1097/GIM.0b013e31821435f7.

PMID:
21546841
12.
13.

Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.

Ciske DJ, Haavisto A, Laxova A, Rock LZ, Farrell PM.

Pediatrics. 2001 Apr;107(4):699-705.

PMID:
11335747
14.

Strategies for basic laboratory diagnostics of the hemoglobinopathies in multi-ethnic societies: interpretation of results and pitfalls.

Giordano PC.

Int J Lab Hematol. 2013 Oct;35(5):465-79. doi: 10.1111/ijlh.12037. Epub 2012 Dec 7. Review.

PMID:
23217050
16.

Factors that influence parents' experiences with results disclosure after newborn screening identifies genetic carrier status for cystic fibrosis or sickle cell hemoglobinopathy.

Collins JL, La Pean A, O'Tool F, Eskra KL, Roedl SJ, Tluczek A, Farrell MH.

Patient Educ Couns. 2013 Mar;90(3):378-85. doi: 10.1016/j.pec.2011.12.007. Epub 2012 Jan 11.

17.

Basic haemoglobinopathy diagnostics in Dutch laboratories; providing an informative test result.

Kaufmann JO, Smit JW, Huisman W, Idema RN, Bakker E, Giordano PC.

Int J Lab Hematol. 2013 Aug;35(4):428-35. doi: 10.1111/ijlh.12038. Epub 2012 Dec 14.

PMID:
23241064
19.

Raising awareness of carrier testing for hereditary haemoglobinopathies in high-risk ethnic groups in the Netherlands: a pilot study among the general public and primary care providers.

Weinreich SS, de Lange-de Klerk ES, Rijmen F, Cornel MC, de Kinderen M, Plass AM.

BMC Public Health. 2009 Sep 15;9:338. doi: 10.1186/1471-2458-9-338.

20.

Prenatal and newborn screening for hemoglobinopathies.

Hoppe CC.

Int J Lab Hematol. 2013 Jun;35(3):297-305. doi: 10.1111/ijlh.12076. Review.

PMID:
23590658

Supplemental Content

Support Center